Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 72

1.

Genomic medicine. Gene expression tests foretell breast cancer's future.

Garber K.

Science. 2004 Mar 19;303(5665):1754-5. No abstract available.

PMID:
15031473
2.
3.

DNA microarrays: vital statistics.

Tilstone C.

Nature. 2003 Aug 7;424(6949):610-2. No abstract available.

PMID:
12904757
4.

Profiling breast cancer by array CGH.

Albertson DG.

Breast Cancer Res Treat. 2003 Apr;78(3):289-98. Review.

PMID:
12755488
5.

Gene-expression signatures in breast cancer.

Ransohoff DF.

N Engl J Med. 2003 Apr 24;348(17):1715-7; author reply 1715-7. No abstract available.

PMID:
12712998
6.

Rating the risk factors for breast cancer.

Singletary SE.

Ann Surg. 2003 Apr;237(4):474-82. Review.

7.

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.

Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP.

Science. 2003 Mar 14;299(5613):1753-5.

8.

Cancer. Developing molecular biomarkers for cancer.

Ransohoff DF.

Science. 2003 Mar 14;299(5613):1679-80. No abstract available.

PMID:
12637728
9.

Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Massoud TF, Gambhir SS.

Genes Dev. 2003 Mar 1;17(5):545-80. Review. No abstract available.

10.

Expression profiling predicts outcome in breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH.

Breast Cancer Res. 2003;5(1):57-8. Epub 2002 Dec 4. No abstract available.

11.

Challenges and opportunities in evaluating diagnostic tests.

Ransohoff DF.

J Clin Epidemiol. 2002 Dec;55(12):1178-82.

PMID:
12547446
12.

Protein microarray technology.

Templin MF, Stoll D, Schrenk M, Traub PC, Vöhringer CF, Joos TO.

Drug Discov Today. 2002 Aug 1;7(15):815-22. Review.

PMID:
12546969
13.

Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray.

Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, Hwang YJ, Kim YI, Han HS, Kim JC, Kim MK.

Mol Cells. 2002 Dec 31;14(3):382-7.

14.

Molecular signatures of breast cancer--predicting the future.

Kallioniemi A.

N Engl J Med. 2002 Dec 19;347(25):2067-8. No abstract available.

PMID:
12490689
15.

A gene-expression signature as a predictor of survival in breast cancer.

van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R.

N Engl J Med. 2002 Dec 19;347(25):1999-2009.

16.

Medical applications of microarray technologies: a regulatory science perspective.

Petricoin EF 3rd, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, Woodcock J, Feigal DW Jr, Zoon KC, Sistare FD.

Nat Genet. 2002 Dec;32 Suppl:474-9. Review.

PMID:
12454641
17.

Microarray standards at last.

[No authors listed]

Nature. 2002 Sep 26;419(6905):323. No abstract available.

PMID:
12352992
18.

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.

Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AL, Brown PO.

Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12963-8. Epub 2002 Sep 24.

19.

Clinical proteomics: translating benchside promise into bedside reality.

Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA.

Nat Rev Drug Discov. 2002 Sep;1(9):683-95. Review.

PMID:
12209149
20.

Biomarkers in cancer screening: a public health perspective.

Srivastava S, Gopal-Srivastava R.

J Nutr. 2002 Aug;132(8 Suppl):2471S-2475S. Review.

Supplemental Content

Support Center